🧬Exclusive Patent License Opportunity for Biomedical Innovations
Prospective Grant of Exclusive License, Inter-Institutional Agreement-Institution Lead: Conductive Polymer Coated Electrodes for Dielectrophoretic Cell Positioning and Electroporation
Summary
The National Institute of Allergy and Infectious Diseases, an institute of the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an exclusive, sublicensable patent license to Cambridge Enterprise Limited, University of Cambridge, located in Cambridge, United Kingdom, to practice the inventions embodied in the patent applications listed in the Supplementary Information section of this notice.
Agencies
- Health and Human Services Department
- National Institutes of Health
Business Impact
$$$ - High
The notice outlines a prospective exclusive patent license grant for innovative technology relevant to human cellular practices, providing potential business opportunities and partnerships for organizations involved in biotechnology and medical device sectors. The timeline for comments and license applications indicates a proactive engagement with potential licensees.